Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|July 1, 2022
Long Non-Coding RNA-TMPO-AS1 as ceRNA Binding to let-7c-5p Upregulates STRIP2 Expression and Predicts Poor Prognosis in Lung AdenocarcinomaJuan Wang, Yixiao Yuan, Lin Tang, et al.
Frontiers in Immunology|February 9, 2026
m6A RNA modification and myeloid-derived suppressor cells: mechanistic insights and clinical prospectsChunhong Li, Xiulin Jiang, Yixiao Yuan, et al.
Medcomm|January 7, 2025
RNA N4-acetylcytidine modification and its role in health and diseasesQiang Wang, Yixiao Yuan, Qiang Zhou, et al.
Frontiers in Immunology|February 27, 2026
Functional roles and mechanisms of circRNA-protein interactions in cancer progression and tumor immune regulationLin Yang, Chunhong Li, Xiulin Jiang, et al.
Aging|September 28, 2022
Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinomaXi Chen, Yixiao Yuan, Fan Zhou, et al.
Frontiers in Oncology|September 18, 2024
Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinomaXi Chen, Jishu Guo, Fan Zhou, et al.
Signal Transduction and Targeted Therapy|February 21, 2021
The role of m6A modification in the biological functions and diseasesXiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Frontiers in Oncology|June 1, 2022
Over-Expression of Long Non-Coding RNA-AC099850.3 Correlates With Tumor Progression and Poor Prognosis in Lung AdenocarcinomaXi Chen, Jishu Guo, Fan Zhou, et al.
Frontiers in Oncology|June 2, 2022
Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung AdenocarcinomaXi Chen, Jishu Guo, Fan Zhou, et al.
Frontiers in Oncology|June 27, 2022
Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma ProgressionXi Chen, Yixiao Yuan, Wenjun Ren, et al.
Pageof 10